-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MrNr7kQ/UgRi2/eUJiQNvNjMDFSikv2xWTonl8rrTdp312AasZc8e+F9yjP+YCb8 fprtdQJZ8gEOp9GVBq8RXw== 0001169232-04-001637.txt : 20040310 0001169232-04-001637.hdr.sgml : 20040310 20040310144015 ACCESSION NUMBER: 0001169232-04-001637 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040305 ITEM INFORMATION: Other events FILED AS OF DATE: 20040310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EZ EM INC CENTRAL INDEX KEY: 0000727008 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 111999504 STATE OF INCORPORATION: DE FISCAL YEAR END: 0529 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-100878 FILM NUMBER: 04659845 BUSINESS ADDRESS: STREET 1: 717 MAIN ST CITY: WESTBURY STATE: NY ZIP: 11590 BUSINESS PHONE: 5163338230 8-K 1 d58747_8-k.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ---------- FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 5, 2004 ------------- E-Z-EM, INC. ------------------------------------------------------ (Exact Name of Registrant as Specified in its Charter) Delaware ---------------------------------------------- (State or Other Jurisdiction of Incorporation) 1-11479 11-1999504 ------------------------ --------------------------------- (Commission File Number) (IRS Employer Identification No.) 1111 Marcus Avenue, Lake Success, New York, NY 11042 - ---------------------------------------------- ---------- (Address of Principal Executive Offices) (Zip Code) (516) 333-8230 ---------------------------------------------------- (Registrant's telephone number, including area code) ITEM 5. OTHER EVENTS AND REQUIRED FD DISCLOSURE On March 5, 2004, AngioDynamics, Inc., E-Z-EM, Inc.'s wholly-owned subsidiary, announced the filing of a registration statement with the Securities and Exchange Commission for an initial public offering of its common stock. A copy of the press release issued by AngioDynamics is being filed as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference in its entirety. SIGNATURES: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: March 10, 2004 E-Z-EM, INC. (Registrant) By: /s/ Anthony A. Lombardo --------------------------------- Anthony A. Lombardo President and Chief Executive Officer 2 EXHIBIT INDEX - ------------- Number Description - ------ ----------- Exhibit 99.1 AngioDynamics, Inc. press release. 3 EX-99.1 3 d58747_ex99-1.txt PRESS RELEASE Exhibit 99.1 ANGIODYNAMICS(R) Company Contacts: Investor Relations Contacts: AngioDynamics, Inc. Lippert/Heilshorn & Associates, Inc. - ------------------- ------------------------------------ Lisa Donegan Kim Sutton Golodetz (kgolodetz@lhai.com) (800) 772-6446 x370 (212) 838-3777 www.angiodynamcis.com Bruce Voss (bvoss@lhai.com) (310) 691-7100 FOR IMMEDIATE RELEASE AngioDynamics Files Registration Statement for Initial Public Offering Queensbury, NY, March 5, 2004 - AngioDynamics, Inc., a wholly owned subsidiary of E-Z-EM, Inc. (AMEX: EZM) today announced that it has filed a registration statement with the Securities and Exchange Commission for an initial public offering of common stock. RBC Capital Markets will act as lead manager and sole book-running manager, and Adams Harkness and Hill will act as co-manager. Prospectuses are not currently available. When available, interested persons may obtain copies of the preliminary prospectus from RBC Capital Markets, 60 South Sixth Street, 17th Floor, Minneapolis, Minnesota 55402. Application is being made to approve the common stock for quotation on the Nasdaq National Market under the proposed symbol "ANGO." A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About AngioDynamics AngioDynamics, Inc. (www.angiodynamics.com) manufactures a wide range of products, including angiographic, dialysis, PTA dilation, thrombolytic, image-guided vascular access, endovascular laser venous system, as well as abdominal infection drainage products. AngioDynamics' focus is on diagnostic and therapeutic products that enable interventional physicians to treat peripheral vascular diseases and other non-coronary diseases. # # # -----END PRIVACY-ENHANCED MESSAGE-----